Aurinia Pharmaceuticals Inc (AUPH)

R&D Expenses

$13.05M

Quarterly · Period ending: · USD

AUPH logo

AUPH R&D Expenses

Latest reported$13.05M
AUPH Quarterly R&D Expenses ($0.00 → $13.05M)
High-resolution chart · PNG

AUPH r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aurinia Pharmaceuticals Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
1,693,382
1,954,554
1,139,958
1,201,321
482,405
1,292,287
-200,729
339,100
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.